Author: GKA

The ongoing coronavirus pandemic, it can be safely said, has necessitated significant and sudden change in many organisations’ operations – and the situation has proved no different here at GKA.  One such notable change has been widespread switching from face-to-face to web-based interviews, the latter using...

Gillian Kenny Associates (GKA) are delighted to announce the appointment of Adam Irwin as Managing Director.

Adam, who has been with the company for 14 years, steps up from his role as Head of Fieldwork with immediate effect. During his time with the business, he has held nearly every position imaginable within the project delivery team. He brings an unrivaled knowledge of both the sector and GKA's client base to the role.

Adam replaces Sophie Zadeh, who has decided to concentrate her efforts on another business she has been involved with for a number of years.

Joining Adam on the revamped leadership team is Jon Loose. Jon has been a key member of the GKA team for almost seven years. In that time, as Head of Technical Development, he has worked closely with Adam on the day-to-day delivery of projects. He will now assume the role of Operations Director.

Patient-centric research is growing in importance in the pharmaceutical industry. It's not just about the science behind different illnesses and medications; today, it's equally important to understand the patient experience of what it really means to live with a condition. As patients become more empowered, take greater control of their health and become key decision-makers in their care, it's vital that their voice is heard. Not only that, but as the pharmaceutical industry becomes more eager to deliver value by enhancing the patient experience, it's really important that researchers choose methodologies for patient market research that enable them to discover the person within the patient.

Millennials are typically defined as those born between the early 1980s through to the late 1990s. Aged between 22-37 years old, this generation accounts for about a quarter of the world's population. Most notably, millennials have grown up with the internet. They are used to having information instantly available at their fingertips and were the generation that led the way in terms of social media and using mobile devices to stay in touch 24/7. But what does this mean for the healthcare industry?

The lowdown Cow's milk allergy (also known as cow's milk protein allergy or CMPA) is an abnormal response by the body's immune system in which proteins in cow's milk are seen as a potential threat. This can cause the immune system to be'sensitised', which means there is the potential that when cow's milk is consumed, the immune system remembers this protein and reacts to it by producing allergic symptoms, which can happen immediately after feeding or at a later time (identified as a delayed reaction).

It's no secret that public satisfaction with the NHS is continuing to decline. But why are satisfaction levels so low? What plans are in place to make improvements? And what does this mean for qualitative research in healthcare? Since 1983, NatCen Social Research's British Social Attitudes survey has asked members of the public in England, Scotland and Wales about their views on the NHS and health and care issues generally. The latest survey, carried out between July and October 2018, asked 2,926 people about their overall satisfaction with the NHS and 973 people about their satisfaction with individual NHS and social care services. We take a look at the results and also compare the findings with the Care Quality Commission's Inpatient Survey, which looks at the satisfaction of patients discharged from an NHS acute hospital, to see if there are any similarities and trends;

  Patient market research is a vital part of medical market research. For starters, patients have a unique view on diseases and treatment. They live with their condition every day and have often tried a number of different treatments and therapies - which means they can provide in-depth insight into what it's really like to live with their conditions. In turn, this insight helps HCPs, pharma companies and researchers see things from a fresh, new perspective.

  Crohn's disease is a lifelong condition in which parts of the digestive system become inflamed. The areas of inflammation are often patchy with sections of normal gut in between, and these inflammation patches may be small or extend quite a distance along part of the gut.

  Lupus is a long-term medical condition that causes inflammation to the joints, skin, and other organs. It's an autoimmune disease that means the body's immune system attacks healthy tissue, and there are two main types of the condition: discoid lupus and systemic lupus erythematosus (SLE). It's not fully understood what causes it, but things such as viral infections, strong medications, sunlight, puberty, childbirth and menopause can all trigger the condition. Unfortunately, there is no cure for lupus, but if treatment starts early then the symptoms can improve.

 Patients have a completely unique view on diseases and treatment. Their perspective is often very different to the physicians that treat them due to the intimate relationship they have with the conditions they are living with, as well as their personal experience of a range of therapy options. As a result, patient market research can provide a huge amount of in-depth insight into what it's like living with these diseases, which can help healthcare professionals and pharma companies see things from a new perspective.